Summary
Panthera Biopartners, a Preston-based clinical trials business, has expanded its operations into mainland Europe through the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), an independent clinical research site network based in Hungary.
Summary of transaction details:
- Value: Undisclosed
- Sector: Healthcare & Biotech
- Advisor: Not mentioned
- Key Entities: Panthera Biopartners (Acquirer), Óbudai Egészségügyi Centrum Kft (OEC) (Target)
- Location: Hungary (Target), Preston, UK (Acquirer)
Note: This acquisition represents a strategic move for Panthera Biopartners to establish a significant presence in the European clinical trials market, leveraging OEC's existing network to facilitate broader patient recruitment and trial management capabilities for Phase II and Phase III clinical trials.
Lead Investor / Acquirer
Panthera Biopartners
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Exited prioritisedOriginal Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in